**Core Concept:** Dysphagia is the clinical presentation of difficulty swallowing, often due to structural or functional abnormalities in the esophagus or gastrointestinal (GI) tract. Intermittent epigastric pain may indicate a GI disorder. Esophagoscopy reveals dilated esophagus above and narrowing at the bottom, which is consistent with achalasia. Achalasia is a motor disorder characterized by loss of peristaltic function and smooth muscle relaxation in the lower esophageal sphincter, leading to difficulty in food passage and pain.

**Why the Correct Answer is Right:** The correct answer is D) Botulinum toxin injection, because it is a minimally invasive treatment modality for achalasia. Botulinum toxin is a neurotoxin that blocks acetylcholine release, causing relaxation of lower esophageal sphincter and improved esophageal peristalsis.

**Why Each Wrong Option is Incorrect:**

A) Medication: This option is incorrect because it does not address the underlying motor disorder in achalasia. Medications may provide symptomatic relief but do not correct the motor dysfunction.

B) Surgery: Surgery is a more invasive option than botulinum toxin injection and carries the risk of complications. Moreover, it addresses the symptom relief rather than the motor dysfunction in achalasia.

C) Endoscopy: Endoscopy is a diagnostic tool used to identify the condition but does not provide a treatment option.

**Clinical Pearl:** Botulinum toxin injection is the preferred treatment for achalasia as it is minimally invasive, provides long-term symptom relief, and addresses the motor dysfunction without causing complications associated with surgery. In addition, it is a safer alternative compared to medications, which only provide symptom relief but do not treat the underlying disorder.